The content on this site is intended for healthcare professionals only
New genetic modelling improves screening for breast cancer
Herceptin Increases event-free survival in locally advanced HER2-postive breast cancer
Zoledronic acid may have anti-tumour properties
Hormone supplements reduce death from breast cancer
Breast cancer patients may have better option to reduce oestrogen levels
Use of written forms doubles breast cancer detection rate
Predictive value of HER2 and topoisomerase II alpha in early breast cancer patients treated with CMF or anthracycline-based adjuvant therapy
Poor prognosis on small, HER2 positive tumours
ECCO 15 - ESMO 34 Executive Scientific Programme Committee
Prophylactic surgery for BRCA1 and BRCA2 carriers
Various molecular imaging devices for non-invasive assessment of protein function and gene-expression pathways
10 new genes increase risk of breast cancer
